Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
Original languageEnglish
Publication year5 Sept 2014
Publication statusPublished - 5 Sept 2014
EventDanish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014 - Hindsgavl Slot, Hindsgavl Allé, 5500 Middelfart, Hindsgavl Allé, 5500 Middelfart, Denmark
Duration: 5 Sept 20146 Sept 2014

Conference

ConferenceDanish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014
LocationHindsgavl Slot, Hindsgavl Allé, 5500 Middelfart
CountryDenmark
CityHindsgavl Allé, 5500 Middelfart
Period05/09/201406/09/2014

See relations at Aarhus University Citationformats

ID: 84594795